Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Debt to Equity (2017)

Dexcom (DXCM) has disclosed Debt to Equity for 8 consecutive years, with $0.27 as the latest value for Q1 2017.

  • On a quarterly basis, Debt to Equity rose 3571.71% to $0.27 in Q1 2017 year-over-year; TTM through Mar 2017 was $0.27, a 3571.71% increase, with the full-year FY2015 number at $0.01, down 68.31% from a year prior.
  • Debt to Equity was $0.27 for Q1 2017 at Dexcom, up from $0.01 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.27 in Q1 2017 to a low of $0.01 in Q1 2016.
  • A 5-year average of $0.07 and a median of $0.05 in 2014 define the central range for Debt to Equity.
  • Peak YoY movement for Debt to Equity: crashed 73.35% in 2016, then surged 3571.71% in 2017.
  • Dexcom's Debt to Equity stood at $0.08 in 2013, then tumbled by 59.42% to $0.03 in 2014, then crashed by 68.31% to $0.01 in 2015, then decreased by 29.28% to $0.01 in 2016, then soared by 3571.71% to $0.27 in 2017.
  • Per Business Quant, the three most recent readings for DXCM's Debt to Equity are $0.27 (Q1 2017), $0.01 (Q1 2016), and $0.01 (Q4 2015).